Riskpilot← Back to searchSign inGet full accessBibbInstruments AB
ABActiveOrg 5569389512Scheelevägen 2Manufacture of irradiation, electromedical and electrotherapeutic equipment · NACE 2660Est. 20131-4 employees
Revenue 2024
SEK 0
EBITDA margin
—
-15% vs 2023
Equity ratio
84.1%
Financial strength
Net profit 2024
SEK -12,7M
-16% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -12,8M | -15% |
| Net profit | SEK -12,7M | -16% |
| Total assets | SEK 33,7M | +1% |
| Equity | SEK 28,4M | -9% |
| Employees | — | — |
Legal name
BibbInstruments AB
Org number
5569389512
Legal form
Aktiebolag
NACE code
2660 · Manufacture of irradiation, electromedical and electrotherapeutic equipment
Founded
12 augusti 2013
Share capital
SEK 2 482 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Firman tecknas ensam av Walther, Charles Stellan Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska utveckla, sälja och licensiera rättigheter för instrument för cancerdiagnostik samt idka därmed förenlig verksamhet.
Address
Scheelevägen 2
Phone
+46708999486
Email
info@bibbinstruments.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 448 | 496 | 0 | 16 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 6 | 1 | −5 098 | −9 787 | −12 058 | 0 | −10 271 | −11 276 | −11 160 | −12 805 |
| Depreciation & amort. | −0 | −0 | — | — | — | — | — | — | — | — |
| EBIT | 6 | 1 | −5 098 | −9 787 | −12 058 | 0 | −10 271 | −11 276 | −11 160 | −12 805 |
| Net financials | — | — | −44 | — | — | — | — | — | 192 | 86 |
| Profit before tax | 4 | 1 | −5 132 | −9 787 | −12 058 | 0 | −10 271 | −11 276 | −10 969 | −12 708 |
| Tax | −2 | −0 | 1 127 | 2 039 | −3 166 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 2 | 1 | −4 005 | −7 748 | −15 224 | 0 | −10 271 | −11 276 | −10 969 | −12 708 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 804 | 1 930 | 14 960 | 27 953 | 30 244 | 33 708 | 23 465 | 34 800 | 33 351 | 33 728 |
| Equity | 314 | 1 068 | 13 819 | 24 965 | 28 423 | 31 796 | 21 525 | 31 770 | 31 218 | 28 379 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 480 | 852 | 1 141 | 2 988 | 1 821 | 1 912 | 1 940 | 3 030 | 2 133 | 5 349 |
| Total debt | 480 | 852 | 1 141 | 2 988 | 1 821 | 1 912 | 1 940 | 3 030 | 2 133 | 5 349 |
EBITDA margin
-1280500000.0%
This company
15.8%
Market median
-8104430480% vs market
20152024
Equity ratio
84.1%
This company
38.2%
Market median
+120% vs market
20152024
Return on equity
-44.8%
This company
18.4%
Market median
-343% vs market
20152024
Net profit margin
-1270800000.0%
This company
8.1%
Market median
-15688888989% vs market
20152024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20152024
Debt / equity
0.19×
This company
0.62×
Market median
+69% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
FN Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
BN Chief Auditor | Chief Auditor | 2024 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2025 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2020 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BibbInstruments AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Fredrik Nils Peter Lindblad | Chief Executive Officer | 0 companies |
| Bengt Niclas Valdemar Frank | Chief Auditor | 0 companies |
| Semmy Rülf | Board of Directors | 0 companies |
| Sara Katarina Lindroth | Board of Directors | 0 companies |
| Stephan Carl-Otto Dymling | Board of Directors | 0 companies |
| Karl Kristian Waldeck | Board of Directors | 0 companies |
| Erik Carl Bernhard von Schenck | Chairman | 0 companies |
| Charles Stellan Walther | Board of Directors | 0 companies |